Sideris Pharmaceuticals Appoints Gregory I. Berk, M.D., As President And Chief Medical Officer
Published: Jan 08, 2014
Sideris Pharmaceuticals, Inc., a biotechnology company developing therapeutics for the treatment of transfusional iron overload diseases, today announced the appointment of Gregory I. Berk, M.D., as its President and Chief Medical Officer. As the Company’s most senior operating executive, he will also join its Board of Directors. Dr. Berk assumes the role of President of Sideris as the company is rapidly advancing its lead product candidate, SP-420, into human clinical trials for iron overload diseases.
Help employers find you! Check out all the jobs and post your resume.